Immunovant stock falls 8% amid Graves’ disease program update Source: Seekingalpha
Month: September 2024
IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Phase 3 examine of their antibody drug conjugate, or ADC, datopotamab deruxtecan didn’t present it…
UniDoc qualifies to partner with U.S. telecommunications companies Source: Seekingalpha
Rockwell Medical enters into product purchase agreement Source: Seekingalpha
American Diversified to acquire GlucoGuard Source: Seekingalpha
Eli Lilly taps veteran Lucas Montarce as new CFO Source: Seekingalpha
Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial Source: Seekingalpha
Terns stock jumps as weight loss drug succeeds in early trial Source: Seekingalpha
Cassava Sciences’ Richard Barry to take helm as permanent CEO Source: Seekingalpha
Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y Source: Seekingalpha